All
- All
- Articles
- Calendar
- Compliance
- Newsletter
- Position Statements
- Press Release
- Regulatory
- Uncategorized
A High-Level Comparison of Homeopathic Product Regulation in the US, EU, and Canada
Two members of the AAHP Board, Mark Land and Eric Foxman, attended a June meeting with members of similar organizations from the European Union (EU),...
Snapshots from There and Then: History of Homeopathy
In honor of AAHP's 100th anniversary year, we're looking back at the history of homeopathy to learn how the medical modality spread worldwide. Readers will...
AAHP Integrative Medicine Retailer Award: History and Philosophy
By Mark Land, M.S., RAC, AAHP President For several years now, food, drug, and mass retailers have recognized the consumer shift toward integrative health. To...
5th International Homeopathic Research Conference
By Mark Land, M.S., RAC, AAHP President The Homeopathic Research Institute (HRI) held its 5th international research conference on homeopathy in London, June 15-18, 2023. The conference theme...
FDA Cracks Down on Testing for Glycerin Contaminants — Again
By Al Lorman, AAHP Counsel The Food and Drug Administration (FDA) has begun another campaign to protect consumers from products that contain glycerin potentially contaminated...
FDA’s Center for Drug Evaluation and Research’s (CDER) Office of Compliance
By Mark Land, M.S., RAC, AAHP President The Office of Compliance (OC) shields patients from poor quality, unsafe, and ineffective drugs through compliance strategies and...
Meet Jill Furman, JD, New Director of FDA’s Office of Compliance
Drug evaluation and research help to ensure drug quality and therefore, public safety. Leading the charge in this critical mission is Jill Furman, J.D., the...
